Lincoln, Nebraska, United States · On-site
Celerion is committed to swift, exceptional clinical research through translational medicine. Every day, we use our experience, agility, and innovative research strategies to help get drugs to market faster. We're seekin…
Skills: Analytical chemistry, Chromatography, Method development, Laboratory testing, Instrumentation maintenance
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
The Instrument Scientist will execute analytical tests to ensure dose formulations meet clinical research specifications and maintain laboratory instrumentation. They will also develop chromatographic methods, prepare quality controls, and document results for sponsors.
Candidates must hold a Bachelor's degree in Chemistry, Biochemistry, or a related field. A minimum of 3-5 years of hands-on experience with analytical instrumentation and method development is highly preferred.
Celerion is committed to swift, exceptional clinical research through translational medicine. Every day, we use our experience, agility, and innovative research strategies to help get drugs to market faster.
We're seeking an Instrument Scientist to join our Dose Formulation team at our facility in Lincoln, NE, located just south of downtown.
In this lab-based role, you'll execute critical tests to ensure compounds from our in-house pharmacy meet all required specifications for use in clinical research trials.
If you're driven by tight timelines and passionate about advancing human health, this could be the role for you. You'll leverage your expertise in analytical chemistry to ensure every dose is ready for delivery on schedule.
Celerion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, age, sexual orientation, gender identity, genetic information, marital status, qualified protected veteran status, or disability.
Note: To make sure you don't miss important updates from us, please check your Spam folder for emails from @celerion.com, particularly interview invitations. If you find one there, mark it as "Not Junk" to ensure future Celerion emails land in your inbox. Please note that Gmail accounts have been particularly noted as routing to Spam.
Celerion Can Take You from First-In-Human through Proof-of-Concept.
Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines. With over 50 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings. Our operations are strategically located in: Lincoln, Nebraska (Corporate Headquarters) Philadelphia, Pennsylvania Phoenix, Arizona Belfast, Northern Ireland,UK Zurich, Switzerland Vienna, Austria Richmond, Virginia Montreal, Quebec, Canada For more information, visit: www.celerion.com
Offices: 621 Rose Street, Lincoln, NE 68502, US · 2420 W. Baseline Rd., Tempe, AZ 85283, US · 100 Boulevard Alexis-Nihon, Montreal, Quebec H4M, CA · 22-24 Lisburn Road, Belfast, BT9 6AD, GB · Allmendstrasse 32, Fehraltorf, CH
Celerion Can Take You from First-In-Human through Proof-of-Concept.
Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines. With over 50 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings. Our operations are strategically located in: Lincoln, Nebraska (Corporate Headquarters) Philadelphia, Pennsylvania Phoenix, Arizona Belfast, Northern Ireland,UK Zurich, Switzerland Vienna, Austria Richmond, Virginia Montreal, Quebec, Canada For more information, visit: www.celerion.com
Offices: 621 Rose Street, Lincoln, NE 68502, US · 2420 W. Baseline Rd., Tempe, AZ 85283, US · 100 Boulevard Alexis-Nihon, Montreal, Quebec H4M, CA · 22-24 Lisburn Road, Belfast, BT9 6AD, GB · Allmendstrasse 32, Fehraltorf, CH
